Chugai Pharmaceutical's Net Income Jumps 31% in Three Months Ended March 31

MT Newswires Live

Apr 25, 2025

Chugai Pharmaceutical (TYO:4519) reported a 31% increase in net income to 97.2 billion yen for the three months ended March 31, from 74.4 billion yen a year ago.

The pharmaceutical group's earnings per share rose to 59.08 yen from 45.21 yen a year ago, according to a Thursday bourse filing.

Revenue jumped 22% to 288.5 billion yen from 236.9 billion yen a year earlier.

For the year ending Dec. 31, the company expects core net income to increase 3.2% to 410.0 billion yen or 250.00 yen per share, while revenue is projected to rise 1.7% to 1.19 trillion yen.

The company plans to pay interim and year-end dividends of 125.00 yen per share each, including a special dividend for its 100th anniversary, totaling 250.00 yen per share for the fiscal year.

Price (JPY): $8285.00, Change: $+34, Percent Change: +0.41%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2530912780"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2530912780\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2530912780?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-25 09:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2530912780","market":"fut","top_or_hot":-1,"title":"Chugai Pharmaceutical's Net Income Jumps 31% in Three Months Ended March 31","media":"MT Newswires Live","content":"<html><body><p> Chugai Pharmaceutical (TYO:4519) reported a 31% increase in net income to 97.2 billion yen for the three months ended March 31, from 74.4 billion yen a year ago.</p><p>The pharmaceutical group's earnings per share rose to 59.08 yen from 45.21 yen a year ago, according to a Thursday bourse filing.</p><p>Revenue jumped 22% to 288.5 billion yen from 236.9 billion yen a year earlier.</p><p>For the year ending Dec. 31, the company expects core net income to increase 3.2% to 410.0 billion yen or 250.00 yen per share, while revenue is projected to rise 1.7% to 1.19 trillion yen.</p><p>The company plans to pay interim and year-end dividends of 125.00 yen per share each, including a special dividend for its 100th anniversary, totaling 250.00 yen per share for the fiscal year.</p><p>Price (JPY): $8285.00, Change: $+34, Percent Change: +0.41%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chugai Pharmaceutical's Net Income Jumps 31% in Three Months Ended March 31</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChugai Pharmaceutical's Net Income Jumps 31% in Three Months Ended March 31\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-25 09:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Chugai Pharmaceutical (TYO:4519) reported a 31% increase in net income to 97.2 billion yen for the three months ended March 31, from 74.4 billion yen a year ago.</p><p>The pharmaceutical group's earnings per share rose to 59.08 yen from 45.21 yen a year ago, according to a Thursday bourse filing.</p><p>Revenue jumped 22% to 288.5 billion yen from 236.9 billion yen a year earlier.</p><p>For the year ending Dec. 31, the company expects core net income to increase 3.2% to 410.0 billion yen or 250.00 yen per share, while revenue is projected to rise 1.7% to 1.19 trillion yen.</p><p>The company plans to pay interim and year-end dividends of 125.00 yen per share each, including a special dividend for its 100th anniversary, totaling 250.00 yen per share for the fiscal year.</p><p>Price (JPY): $8285.00, Change: $+34, Percent Change: +0.41%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JPY","symbol_name":"Lazard Japanese Equity ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2530912780","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530912780","pubTimestamp":1745545072,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Chugai Pharmaceutical  reported a 31% increase in net income to 97.2 billion yen for the three months ended March 31, from 74.4 billion yen a year ago.The pharmaceutical group's earnings per share rose to 59.08 yen from 45.21 yen a year ago, according to a Thursday bourse filing.Revenue jumped 22% to 288.5 billion yen from 236.9 billion yen a year earlier.For the year ending Dec. 31, the company expects core net income to increase 3.2% to 410.0 billion yen or 250.00 yen per share, while revenue is projected to rise 1.7% to 1.19 trillion yen.The company plans to pay interim and year-end dividends of 125.00 yen per share each, including a special dividend for its 100th anniversary, totaling 250.00 yen per share for the fiscal year.Price : $8285.00, Change: $+34, Percent Change: +0.41%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JPY":"Lazard Japanese Equity ETF"},"translate_title":"中外制药截至3月31日的三个月净利润跃升31%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JPY":1},"content_text":"Chugai Pharmaceutical (TYO:4519) reported a 31% increase in net income to 97.2 billion yen for the three months ended March 31, from 74.4 billion yen a year ago.The pharmaceutical group's earnings per share rose to 59.08 yen from 45.21 yen a year ago, according to a Thursday bourse filing.Revenue jumped 22% to 288.5 billion yen from 236.9 billion yen a year earlier.For the year ending Dec. 31, the company expects core net income to increase 3.2% to 410.0 billion yen or 250.00 yen per share, while revenue is projected to rise 1.7% to 1.19 trillion yen.The company plans to pay interim and year-end dividends of 125.00 yen per share each, including a special dividend for its 100th anniversary, totaling 250.00 yen per share for the fiscal year.Price (JPY): $8285.00, Change: $+34, Percent Change: +0.41%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}